Lesinurad: a novel treatment drug for gout
CHEN Qing;TIE Yuan;HU Yong-chuan;LIU Lei;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Science;Peking University Health Science Center;Department of Pharmacy;Beijing Hospital;

..............page:1441-1445

Quality re-evaluation and clinical use of generic entecavir products
LIU Shi-ting;Nanfang Hospital;Nanfang Medical University;

..............page:1446-1450

Comparative analysis of each edition of WHO Model List of Essential Medicines for Children and Chinese National Essential Medicine List(2012 edition)
CHEN Zhe;XIE Xiao-hui;WANG Xiao-ling;YAN Han;ZHANG Meng;CUI Jia-yu;School of Pharmaceutical Sciences;Peking University;Beijing Children’s Hospital Affiliated to the Capital Medical University;

..............page:1451-1455

The situation and comments on the chemical drug guidelines of China
JIANG Dian-zhuo;Center for Drug Evaluation;China Food and Drug Administration;

..............page:1456-1460

Evaluation of innovation efficiency of pharmaceutical manufacturing industry in China based on SFA
TAN Xiao-dong;CHEN Yu-wen;Shenyang Pharmaceutical University;

..............page:1461-1465

Improving effect of volvalerenal K from Valeriana officinalis Linn.var. latiofolia miq on learning and memory abilities in APPswe/PS1E9 double-transgenic AD mouse model
CHEN Heng-wen;WANG Jie;Guang’anmen Hospital;China Academy of Chinese Medicine Science;

..............page:1466-1470

Application of RP-HPLC assay to detect the protein content of finished products of recombinant porcine interferon α
ZHA Ying-li;ZHAO Yu;QI Shi-mei;ZHAO Jun;YU Hai-yang;WANG Ming-li;Anhui Medical University;Anhui Jiuchuan Biological Technology Co.;Ltd.;

..............page:1471-1474

The use of radiolabeled drugs in drug metabolism and disposition studies
HARNUD Sechenchogt;HUANG Ling-li;YUAN Zong-hui;National Reference Laboratory of Veterinary Drug Residues and MOA Key Laboratory for the Detection of Veterinary Drug Residues in Foods;Huazhong Agricultural University;College of Plant Science and Technology of Hubei Engineering University;The Hubei Key Laboratory of Quality Safety Control of Characteristic Fruits and Vegetables;

..............page:1475-1484

Perioperative applications of dexmedetomidine in pediatrics
WANG Guang;JIANG Lu-yang;Department of Anesthesiology;Peking University People’s Hospital;

..............page:1485-1488

Advance in research of large hollowed nanoparticulate aggregates for pulmonary delivery
YANG Hong-ge;LIN Shao-hui;CHEN Jian-hua;XIE Ying;Department of Pharmaceutics;School of Pharmaceutical Sciences;Peking University;School of Medicine;Jianghan University;

..............page:1489-1495

Efficacy of mannitol for prevention of acute kidney injury: a Meta-analysis
ZHENG Dan-dan;YANG Bing;LIU Zhi-yan;HAN Ru;ZHAO Rong-sheng;Pharmacy Department;Peking University Third Hospital;Peking University;Department of Pharmacy Administration and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University;

..............page:1496-1504

Clinical tolerability of Qiweiqingyan Aerosol with changed and unchanged pharmaceutical propellant
HU Chao;ZHENG Jing;MIAO Jia;SHU Shi-qing;LIU Wen;WANG Ying;ZHU Xiao-hong;Phase I Clinical Research Unit;West China Hospital;Sichuan University;

..............page:1505-1510

Preparation of compound temozolomide liposomes and its anti-proliferation effect in vitro
WANG Ya-hua;YING Xue;XUAN Ya-ru;YAN He-lu;ZHANG Chun-chun;LI Xia;TANG Hui;Key Laboratory of Xinjiang Endemic Phytomedicine Resources;Ministry of Education;School of Pharmacy;Shihezi University;

..............page:1511-1516

Effect of EGCG on the expression of TLR4 and its downstream signal transduction pathway in human THP-1 monocytes
WANG Ting;ZHOU Hong;XIA Long-fei;HE Chao;YU Yin-jing;CHENG Si;School of Medicine;Jiangsu University;

..............page:1517-1521

Synthesis and preliminary research of quinoline derivatives as multi-targeted receptor tyrosine inhibitors
LI Wei;LEI Chun-hua;WANG Li-qiang;YUE Hai-tao;Molecular Medicine Research Institute;Huaqiao University;Guangzhou Youmijian Pharmaceutical Technology Co.;Ltd.;

..............page:1522-1530

Synthesis of the DPP-Ⅳ inhibitor DBPR108
JIANG Guo-you;ZHANG Yong;CAO Wen-ting;College of Chemical and Pharmaceutical Engineering;Hebei University of Science and Technology;State Key Laboratory Breeding Base-Key Laboratory of Molecular Chemistry for Drug of Hebei Province;

..............page:1531-1534

Synthesis of the non-ionic X-ray contrast medium iopromide
CHENG Qing-fang;WANG Qi-fa;WANG Jing-wen;ZHANG Jin-biao;WANG Shan-shan;Jiangsu Marine Resources Development Research Institute;School of Pharmacy;Huaihai Institute of Technology;

..............page:1535-1537

Determination of entrapment efficiency of water insoluble drug coumarin 6-loaded PLGA nanoparticles by ultrafiltration
LI Xue-chun;DONG Xiao-xu;ZHANG Ling-ling;FU Jing;NI Jian;School of Chinese Materia Medica;Beijing University of Chinese Medicine;

..............page:1538-1542

Metabolic stability of salvianolic acid B and dimethyl lithospermate B in human liver microsomes and metabolite identification
YUAN Chun-ping;HOU Hui-min;ZENG Shan;National Pharmaceutical Engineering Research Center;China State Institute of Pharmaceutical Industry;Guangdong Medi-World Pharmaceutical Company Limited;

..............page:1543-1549

Determination of uptake of rosuvastatin in Caco-2 cells by LC-MS/MS
XU Qing-qing;HUANG Chen-rong;WANG Zi-teng;ZHANG Shi-chao;MIAO Li-yan;College of Pharmaceutical Sciences;Soochow University;Department of Pharmacy;The First Affiliated Hospital;Soochow University;

..............page:1550-1554

Meta-analysis of immune-related adverse events of ipilimumab for advanced malignant tumors
XIA Tai-yu;CHEN Chuan;REN Qing-lan;Department of Oncology;the People’s Hospital of Dazu District;Department of Oncology;the First Affiliated Hospital of Chongqing Medical University;

..............page:1555-1560